Low-Cost OCT Device for Retinal Imaging

This trial tests a new, affordable device for capturing images of the retina at the back of the eye. The goal is to determine if the Low-Cost OCT-a/LCI Device can produce images as clear as those from more expensive machines and accurately measure retina structures. Individuals with Alzheimer's or those who are healthy and have no major eye issues, such as glaucoma or past eye surgeries (except cataract surgery), may be suitable candidates. Participants should not have diabetes or severe vision problems worse than 20/40. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could make eye imaging more accessible.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that affordable optical coherence tomography (OCT) devices hold promise for safe and non-invasive eye scans. One study tested a new OCT scanner and found it produced images 95% as clear as those from current commercial devices, indicating the new device works effectively without causing harm.

The development of these devices aims to make eye care more accessible by reducing costs and simplifying use. Studies with these low-cost OCT devices have reported no negative effects, suggesting they are well-tolerated by patients.

Researchers are excited about this trial because it explores a low-cost OCT device for retinal imaging, which could make it easier and more affordable to examine retinal changes, especially for people with Alzheimer's disease. Unlike traditional retinal imaging methods, which can be expensive and less accessible, this device aims to provide detailed insights into retinal morphology at a fraction of the cost. The device's advanced imaging technology, specifically the OCT-a/LCI, offers a new way to potentially detect early signs of Alzheimer’s through the eyes, providing a non-invasive and innovative approach to diagnosis and monitoring.

Research has shown that examining the retina, the back part of the eye, can help detect Alzheimer's disease. A special scan called optical coherence tomography (OCT) captures detailed images of the retina, revealing changes linked to Alzheimer's. Studies have found that certain patterns in these images can identify early Alzheimer's with high accuracy. For example, one study found that OCT images could correctly classify Alzheimer's over 98% of the time. This trial will test a low-cost OCT device for retinal imaging, which could effectively spot early signs of Alzheimer's through retinal changes, making it a promising and accessible screening tool.¹³⁶⁷⁸